Insight Capital Research & Management’s Allergan plc AGN Stock Holding History

Insight Capital Research & Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-818	Closed	-$222K	–	119
2015 Q3	$222K	Sell	818 -17,025	-95%	-$5.23M	0.07%	89
2015 Q2	$5.42M	Buy	17,843 +6,172	+53%	+$1.84M	1.43%	26
2015 Q1	$3.47M	Buy	+11,671	New	+$3.33M	0.87%	56
2014 Q3	–	Sell	-16,712	Closed	-$3.73M	–	152
2014 Q2	$3.73M	Buy	+16,712	New	+$3.46M	0.85%	49
2014 Q1	–	Sell	-14,668	Closed	-$2.46M	–	165
2013 Q4	$2.46M	Sell	14,668 -89	-0.6%	-$13.9K	0.55%	71
2013 Q3	$2.28M	Buy	+14,757	New	+$1.97M	0.55%	62

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Insight Capital Research & Management's AGN Position: Q4 2015 in Review

Insight Capital Research & Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 818 shares — an estimated $222K sold.

Insight Capital Research & Management first reported a position in AGN in Q3 2013 and held it in 6 quarters. The position peaked at $5.42M in Q2 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

Insight Capital Research & Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
Insight Capital Research & Management sold 818 Allergan plc shares in Q4 2015, an estimated $222K.
Insight Capital Research & Management first reported a position in Allergan plc in Q3 2013 and held it in 6 quarters.
Insight Capital Research & Management's Allergan plc position peaked at $5.42M in Q2 2015.
1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Insight Capital Research & Management's 13F filing for Q4 2015, filed 8 Feb 2016.